About TechsoMed
TechsoMed is a company based in Rehovot (Israel) founded in 2012. TechsoMed has raised $9.6 million across 3 funding rounds from investors including Screen Holdings, European Union and Axil Capital. TechsoMed offers products and services including BioTrace and BioTrace.IO. TechsoMed operates in a competitive market with competitors including Butterfly Network, Exo, Zonare Medical Systems, SonoSite and Monteris, among others.
- Headquarter Rehovot, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Techsomed Medical Technologies Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.6 M (USD)
in 3 rounds
-
Latest Funding Round
$7 M (USD), Series B
Mar 03, 2021
-
Investors
Screen Holdings
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TechsoMed
TechsoMed offers a comprehensive portfolio of products and services, including BioTrace and BioTrace.IO.
Software for predicting tissue response in ablation therapy.
Tool for planning and confirming treatments in oncology.
People of TechsoMed
Unlock access to complete
Unlock access to complete
Funding Insights of TechsoMed
TechsoMed has successfully raised a total of $9.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TechsoMed
TechsoMed has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Screen Holdings, European Union and Axil Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are targeted by Axil Capital, a VC firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investment firm backed by the Cohen family
|
Locked | Locked | Locked |
Investor details for TechsoMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TechsoMed
Investment portfolio details for TechsoMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TechsoMed
Detailed financials for TechsoMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Techsomed Comparisons
Peer comparison for TechsoMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TechsoMed
TechsoMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, Exo, Zonare Medical Systems, SonoSite and Monteris, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld ultrasound devices are developed for whole-body medical imaging.
|
|
| Locked | Locked | Locked |
Ultrasound images are analyzed via AI-based software provided by Exo.
|
|
| Locked | Locked | Locked |
Portable ultrasound systems are developed and provided for medical use.
|
|
| Locked | Locked | Locked |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| Locked | Locked | Locked |
MRI-guided laser ablation tools for neurosurgery are developed.
|
|
| Locked | Locked | Locked |
Deep learning-based imaging diagnostics for heart diseases are developed.
|
Detailed competitors of TechsoMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Techsomed
Complete news archive for TechsoMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TechsoMed
TechsoMed was founded in 2012 and raised its 1st funding round 7 years after it was founded.
TechsoMed is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
TechsoMed is a funded company, having raised a total of $9.6M across 3 funding rounds to date.
TechsoMed was founded in 2012 in Rehovot, Israel, and operates in the medical technology sector. Real-time monitoring systems based on ultrasound are developed for thermal ablation procedures. The Biotrace unit, an imaging and analysis tool, is interfaced with standard ultrasound devices to track and predict tissue destruction progression. Operations focus on enabling precise control during ablation treatments in clinical settings.
TechsoMed's top competitors include Butterfly Network, Exo and Zonare Medical Systems.
TechsoMed offers BioTrace and BioTrace.IO.
TechsoMed has 11 investors. Key investors include Screen Holdings, European Union, Axil Capital, Yongjin Group, and Cobro Ventures.